5 Spam-Free Article(s) Found
||Take-Two Interactive Software, Inc.
Apr 17, 2019 - Kamada (KMDA) wins the FDA acceptance for the path forward regarding its inhaled Alpha-1-Antitrypsin product, currently under development for treating Alpha-1 Antitrypsin Deficiency.
May 01, 2019 - Sunesis Pharmaceuticals' (SNSS) operating expenses are expected to be higher in the first quarter due to clinical studies on its lead pipeline candidate, vecabrutinib.
May 16, 2019 - Investors appear unmoved with interim data from an open-label Phase 1/2 clinical trial evaluating Takeda's (TAK -2.4%) oral TKI inhibitor TAK-788 in non-small cell lung cancer (NSCLC) patients
Mar 05, 2019 - Companies in the news are;
PLCE, BIIB, NITE, ASND and TAK
Apr 26, 2019 - Seattle Genetics (SGEN) betters loss estimates in Q1 and also rides high on revenue beat.